Global News

Foundry Medical Innovations to re-tool with merger and name change

Wednesday, May 20, 2015 03:19 PM

Foundry Medical Innovations, a Carslbad, Calif.-based comprehensive medical and diagnostic device development company, has merged with Zeis Consulting Group, a provider of IVD clinical research, and changed its name to Toolbox Medical Innovations to better leverage its strengths and serve its growing list of clients.

More... »

Quest Diagnostics

AstraZeneca to invest in new biologics manufacturing facility in Södertälje, Sweden

Wednesday, May 20, 2015 03:18 PM

AstraZeneca plans to invest approximately $285 million in a new high-tech facility for manufacturing of biological medicines in Södertälje, Sweden. The new plant will be focused on filling and packaging of protein therapeutics. The new facility will supply medicines for clinical trial programs of AZ and MedImmune, the company's global biologics R&D arm, from the end of 2018, and will deliver finished products for commercial use once fully operational by 2019.

More... »

Lannett to acquire Silarx Pharmaceuticals

Wednesday, May 20, 2015 03:17 PM

Lannett, a Philadelphia, Pa.-based developer and marketer of generic pharmaceutical products, has signed a definitive agreement to acquire privately held, New York-based Silarx Pharmaceuticals and a related real estate entity, a manufacturer and marketer of liquid generic pharmaceutical products. The transaction is expected to close in early June, subject to customary closing conditions. Strategic benefits of the acquisition include an FDA-approved manufacturing facility, research R&D experience and added diversity to Lannett’s portfolio of existing and pipeline products.  

More... »

Janssen, Rutgers School of Engineering expand collaboration

Wednesday, May 20, 2015 03:13 PM

Janssen Supply Chain has expanded its partnership with the Rutgers University School of Engineering by providing over $6 million to expand ongoing research efforts supporting the company’s introduction of continuous manufacturing techniques for pharmaceuticals.

More... »

Quintiles VP Dr. Judith Beach joins ACRES board of directors

Monday, May 18, 2015 02:23 PM

The Alliance for Clinical Research Excellence and Safety (ACRES) has added Dr. Judith Beach, senior vice president and senior associate general counsel for regulatory affairs at Quintiles, to its board of directors. Beach brings her wide-ranging experience in legal and regulatory counsel on international and domestic regulatory issues in the pharmaceutical, medical device and biotechnology industries, as well as her chief privacy officer responsibilities, to ACRES mission of building a global system for accountable clinical research.

More... »

Endo to acquire Par Pharmaceutical for $8 billion

Monday, May 18, 2015 01:06 PM

Ireland-based Endo International has agreed to acquire privately held, Woodcliff Lake, N.J.-based Par Pharmaceutical from TPG for $8.05 billion, including assumption of Par debt. The transaction has been unanimously approved by the boards of directors of both Endo and Par and is supported by the management teams of both companies. There are no further shareholder approvals required.

More... »

Circassia to acquire Aerocrine and Prosonix

Monday, May 18, 2015 01:03 PM

Circassia Pharmaceuticals has made an all cash offer to acquire Aerocrine, a Swedish company focused on the development and commercialization of medical diagnostic products for use in the diagnosis and management of patients with asthma, for up to $216.4 million.

More... »

Genzyme, Ablynx collaborate on multiple sclerosis research project

Monday, May 18, 2015 12:58 PM

Ablynx, a biopharma company headquartered in Belguim, has entered into an exclusive research collaboration with Genzyme, a Sanofi company, to investigate nanobodies against a multiple sclerosis (MS) target specifically aligning with Genzyme's early-stage MS research programs involving neuroprotection and CNS repair.

More... »

Build a web site for your clinical trial

Monday, May 18, 2015 08:00 AM

Technology has amazing potential in clinical research, although often it is met with reluctance, resulting in slower adoption.

More... »

DAC Patient Recruitment Services takes home gold in the 2015 Hermes Creative Awards

Friday, May 15, 2015 02:36 PM

DAC Patient Recruitment Services, a patient recruitment and retention for global clinical trials company, earned a Gold Award in the 2015 Hermes Creative Awards. Hermes awards are presented to those entries judged to exceed the high standards of the industry norm.

More... »



May 26

inVentiv Health aims to help sponsors prepare for new E.U. regulations on observational studies

ACRP partners with CRO Analytics to measure investigative sites' views of clinical trial quality

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Job satisfaction mixed as workload increases
Salaries not keeping pace with rise in work, responsibilities

Gamification moving from early science to patient use
Pharma looking to use games for early diagnosis, recruitment, adherence

Already a subscriber?
Log in to your digital subscription.

Purchase the May issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs